Insider Transactions in Q3 2021 at Ab Cellera Biologics Inc. (ABCL)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2021
|
Michael R Hayden Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
270,000
+17.49%
|
$4,590,000
$17.73 P/Share
|
|
Sep 01
2021
|
Ester Falconer Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
875,000
+50.0%
|
$14,000,000
$16.89 P/Share
|
|
Sep 01
2021
|
John Hamer Director |
SELL
Open market or private sale
|
Direct |
137,351
-51.59%
|
$2,197,616
$16.93 P/Share
|
|
Aug 31
2021
|
John Hamer Director |
SELL
Open market or private sale
|
Direct |
162,649
-37.93%
|
$2,602,384
$16.95 P/Share
|
|
Aug 16
2021
|
John S. Montalbano Director |
BUY
Open market or private purchase
|
Direct |
6,000
+18.75%
|
$102,000
$17.23 P/Share
|